HopeStage
Back to all studies
CompletedNCT05956483

Testing a rapid mood screener for depression or bipolarity

About this title

Study to Assess Accuracy of Rapid Mood Screener in Adult Participants With Unipolar Major Depressive Disorder or Bipolar 1 Disorder in Real World Setting

Read the official source — NCT05956483
Observational studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Costa Mesa and 8 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 4, 2023
Recruitment status
Completed
Enrollment listed in the registry
423
Sponsor
AbbVie
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05956483
Official title
Show the full official title

A Confirmatory Study of the Rapid Mood Screener for Bipolar 1 Disorder to Evaluate Capability to Distinguish Between Subjects With Unipolar Major Depressive Disorder and Bipolar 1 in a Real-world Setting

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Costa Mesa · Cromwell · Doral

5 more locations
  • Miami
  • North Miami Beach
  • Okeechobee
  • Tampa
  • Monsey

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AbbVie.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies